Peng Wang
Directeur Général chez Worldwide Biotech & Pharmaceutical Co.
Provenance du réseau au premier degré de Peng Wang
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Worldwide Biotech & Pharmaceutical Co.
 Worldwide Biotech & Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Worldwide Biotech and Pharmaceutical Corp. develops, manufactures, and markets pharmaceuticals. Through its subsidiaries, it engages in the research and development, manufacture and distribution of in vitro diagnostics, human vaccine, biomedicines, traditional Chinese medicines, synthetic medicines and medical devices with frontier technologies. The company was founded in 1961 and is headquartered in Xi'an, China.
6
| Private Company | Pharmaceuticals: Major | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peng Wang via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Yangling Daiying Biotech & Pharmaceutical Group Co. Ltd. | Founder Corporate Officer/Principal | ||
| Xi'an Jiaotong University | College/University | Graduate Degree | |
| China Primary Health Care Foundation | Corporate Officer/Principal | ||
| Chinese People's Political Consultative Conference of Shaanxi | Corporate Officer/Principal | ||
Xinhua News Agency
 Xinhua News Agency Publishing: NewspapersConsumer Services Xinhua New Agency serves as the state news agency of the People's Republic of China. It collects and distributes news information. It also offers online news services and publishes newspapers and magazines. The company was founded on November 7, 1931 and is headquartered in Beijing, China. | Publishing: Newspapers | Corporate Officer/Principal | |
| Xi An Medical College | College/University | Undergraduate Degree | |
Nanjing Meirui Pharma Co. Ltd.
 Nanjing Meirui Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Nanjing MeiRui Pharma Co., Ltd., is a Chinese ethical pharmaceutical company specializing in products to treat and diagnose urological conditions. MeiRui is one of the leaders in therapeutics for the treatment of BPH and is constantly expanding its product offerings to treat and diagnose related conditions. The Company works closely with the Chinese Urological Association to develop enhanced standards for the treatment of urological diseases and new therapies for their care. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Tianjin University | College/University | Graduate Degree |
Statistiques
Internationale
| Chine | 9 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 2 |
Opérationnelle
| Corporate Officer/Principal | 5 |
| Director/Board Member | 4 |
| Graduate Degree | 2 |
| President | 1 |
| Founder | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Wexina Guo | 5 |
| Yuan Cheng | 5 |
| Qiang Li | 2 |
| Tian Xi Wang | 1 |
| Zeng Fu Lee | 1 |
| Wei Hong Zhai | 1 |
